High dose chlorambucil in the treatment of lymphoid malignancies

Leukemia and Lymphoma

Volumn 45, Issue 2, 2004, Pages 271-275

  Nicolle, Annette ^a   Proctor, Stephen J ^a   Summerfield, Geoffrey P ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Department of Haematology ^*  (United Kingdom)

Author keywords

Chlorambucil; Chronic lymphocytic leukemia; Clinical trials; High dose; Hodgkin's disease; Non Hodgkin; s lymphoma

Indexed keywords

ALPHA INTERFERON; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; INTERFERON; LOMUSTINE; PHENYLACETIC ACID DERIVATIVE; PREDNISOLONE; PREDNISONE; STEROID; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER REGRESSION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONFUSION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG RESPONSE; DRUG TOLERABILITY; EPITHELIUM TUMOR; EVIDENCE BASED MEDICINE; FLAPPING TREMOR; GASTROINTESTINAL DISEASE; HALLUCINATION; HERPES; HODGKIN DISEASE; HUMAN; INFECTION; INFERTILITY; LIVER TOXICITY; METASTASIS; MYELODYSPLASTIC SYNDROME; MYOCLONUS; NEUTROPENIA; NONHODGKIN LYMPHOMA; OUTPATIENT CARE; PANCYTOPENIA; PRIORITY JOURNAL; SEIZURE; SEPSIS; STATISTICAL ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, ALKYLATING; CHLORAMBUCIL; CLINICAL TRIALS; HODGKIN DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; LYMPHOMA, NON-HODGKIN; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS; TREATMENT OUTCOME; VIDARABINE;

EID: 0842322870     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001595704     Document Type: Article

References (25)

1. Ezdlini, E.Z. and Stutzman, L. (1965) "Chlorambucil therapy for lymphomas and chronic lymphocytic leukemia", Journal of the American Medical Association, 191, 100-106.
2. Galton, D.A.G., Wiltshaw, E., Szur, L. and Dacie, J.V. (1961) "The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukaemia", British Journal of Haematology, 7, 73-98.
3. Alberts, D.S., Chang, S.Y., Chen, H.-S.G., Larcom, B.J. and Jones, S.E. (1979) "Pharmacokinetics and metabolism of chlorambucil in man", Cancer Treatment Reviews, 6(suppl.), 33-42.
4. Begleiter, A., Mowat, M., Israels, L.G. and Johnston, J.B. (1996) "Chlorambucil in chronic lymphocytic leukemia: mechanism of action", Leukemia and Lymphoma, 12, 187-201.
5. Silvennoinen, R., Malminiemi, K., Maliminiemi, O., Seppala, E. and Vilpo, J. (2000) "Pharmacokinetics of chlorambucil in patients with chronic lymphocytic leukaemia: comparison of different days, cycles, doses", Pharmacology & Toxicology, 87, 223-228.
6. Kimby, E., Brandt, L., Nygren, P. and Glimelius, B. (2001) "A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia", Acta Oncologica, 40, 224-230.
7. CLL Trialists Collaborative Group (1999) "Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomised trials", Journal of the National Cancer Institute, 91, 861-868.
8. Jaksic, B. and Brugiatelli, M. (1988) "High dose continuous chlorambucil versus intermittent chlorambucil plus prednisolone for the treatment of B-CLL: IGCI CLL-01 trial", Nouvelle Revue Francaise d'Hematologie, 30, 437-442.
9. Jaksic, B., Brugiatelli, M., Krc, I., Losonczi, H., Holowiecki, J., Planinc-Pereica, A., et al. (1997) "High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine and prednisolone regimen in the treatment of patients with advanced B cell chronic lymphocytic leukaemia", Cancer, 79, 2107-2114.
10. Jaksic, B., Brugiatelli, S., Suciu, S., Beaumelou, E., Wijermans, P.W., Delmer, A., et al. (2000) "Fludarabine vs. high dose chlorambucil in advanced B-cell chronic lymphocytic leukemia (B-CLL : results of EORTC phase II randomised trial after 4 years of median follow-up", Blood, 96, 758a (abstract 3280).
11. Summerfield, G.P., Taylor, P.R.A., Mounter, P.J. and Proctor, S.J. (2002) "High dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low grade non-Hodgkin's lymphoma", British Journal of Haematology, 116, 781-786.
12. Morrison, V.A., Rai, K.R., Peterson, B.L., Kolitz, J.E., Elias, L., Appelbaum, F.R., et al. (2001) "Impact of therapy with chlorambucil, fludarabine or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia (CLL): Intergroup Study Cancer and Leukaemia Group B 9011", Journal of Clinical Oncology, 19, 3611-3621.
13. Rai, K.R., Peterson, B.L., Appelbaum, F.R., Kolitz, J., Elias, L., Shepherd, L., et al. (2000) "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia", New England Journal of Medicine, 343, 1750-1757.
14. Robak, T., Blonski, J.Z., Kasznicki, M., Blasinska-Morawiec, M., Krykowski, E., Dmoszynska, A., et al. (2000) "Cladribine with prednisone versus chlorambucil with prednisone as first line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial", Blood, 96, 2723-2729.
15. Portlock, C.S., Fischer, D.S., Cadman, E., Lundberg, W.B., Levy, A., Bobrow, S., et al. (1987) "High-dose pulse chlorambucil in advanced, low grade non-Hodgkin's lymphoma", Cancer Treatment Reports, 71, 1029-1031.
16. Joseph, G., Hadley, T., Djulbegovic, B., Hamm, J., Seeger, J., Blumenreich, M., et al. (1993) "High-dose chlorambucil and dexamethasone for relapsed non-Hodgkin's lymphomas", American Journal of Clinical Oncology, 16, 319-322.
17. Taylor, P.R.A., Jackson, G.H., Galloway, M.J., Soukop, M., Tinegate, H., Angus, B., et al. (2000) "Primary treatment of low grade non-Hodgkin's lymphoma using an oral anthracycline containing regimen: chlorambucil, idarubicin, dexamethasone (CID) - a phase II study", Cancer Chemotherapy and Pharmacology, 36, 63-68.
18. Lennard, A.L., Carey, P.J., Jackson, G.H. and Proctor, S.J. (1990) "An effective oral combination in advanced relapsed Hodgkin's disease: prednisolone, etoposide, chlorambucil and CCNU", Cancer Chemotherapy & Pharmacology, 26, 301-305.
19. Clark, R.H., Dimitrov, N.V., Axelson, J.A., Charamella, L.J. and Stott, P.B. (1989) "A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapy", American Journal of Clinical Oncology, 12, 75-77.
20. Chisesi, T., Congiu, M., Contu, A., Coser, P., Moretti, L., Porcellini, A., et al. (1991) "Randomized study of chlorambucil (CB) compared to interferon (alfa-2b) combined with CB in low-grade non-Hodgkin's lymphoma: an interim report of a randomized study. Non-Hodgkin's Lymphoma Co-operative Study Group", European Journal of Cancer, 27(suppl 4), S31-S33.
21. Salloum, E., Khan, K.K. and Cooper, D.L. (1997) "Chlorambucil-induced seizures", Cancer, 79, 1009-1013.
22. Ciobanu, N., Runowicz, C., Gulcap, R., Frank, M., Charuvanki, V., Kaufman, D., et al. (1987) "Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinoma", Cancer Treatment Reports, 71, 1324-1325.
23. Wyllie, A.R., Bayliff, C.D. and Kovacs, M.J. (1997) "Myoclonus due to chlorambucil in two adults with lymphoma", Annals of Pharmacotherapy, 31, 171-174.
24. Dighiero, G., Maloum, K., Desablens, B., Cazin, B., Navarro, M., Leblayt, R., et al. (1998) "Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia", New England Journal of Medicine, 338, 1506-1514.
25. Morrison, V.A., Rai, K.R., Peterson, B.L., Kolitz, J.E., Elias, L., Appelbaum, H.R., et al. (2002) "Therapy related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011", Journal of Clinical Oncology, 20, 3878-3884.